Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Medpace Holdings Inc (NASDAQ: MEDP) closed at $447.92 in the last session, down -1.13% from day before closing price of $453.05. In other words, the price has decreased by -$1.13 from its previous closing price. On the day, 0.64 million shares were traded. MEDP stock price reached its highest trading level at $448.81 during the session, while it also had its lowest trading level at $431.89.
Ratios:
We take a closer look at MEDP’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 271.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.70. For the most recent quarter (mrq), Quick Ratio is recorded 0.43 and its Current Ratio is at 0.43. In the meantime, Its Debt-to-Equity ratio is 0.87 whereas as Long-Term Debt/Eq ratio is at 0.72.
On July 23, 2025, TD Cowen Downgraded its rating to Sell which previously was Hold but kept the price unchanged to $366.
On June 24, 2025, Barclays started tracking the stock assigning a Equal Weight rating and target price of $300.Barclays initiated its Equal Weight rating on June 24, 2025, with a $300 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 28 ’25 when EWALD STEPHEN P sold 3,000 shares for $450.00 per share. The transaction valued at 1,350,000 led to the insider holds 10,343 shares of the business.
BURWIG SUSAN E sold 7,500 shares of MEDP for $3,376,050 on Jul 28 ’25. The Exec. VP, Operations now owns 57,500 shares after completing the transaction at $450.14 per share. On Jul 28 ’25, another insider, Troendle August J., who serves as the CEO of the company, sold 48,487 shares for $451.69 each. As a result, the insider received 21,901,093 and left with 962,615 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MEDP now has a Market Capitalization of 12583416832 and an Enterprise Value of 12686929920. As of this moment, Medpace’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.31, and their Forward P/E ratio for the next fiscal year is 28.96. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.27. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.64 while its Price-to-Book (P/B) ratio in mrq is 72.82. Its current Enterprise Value per Revenue stands at 5.685 whereas that against EBITDA is 25.049.
Stock Price History:
The Beta on a monthly basis for MEDP is 1.46, which has changed by 0.1709714 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, MEDP has reached a high of $501.30, while it has fallen to a 52-week low of $250.05. The 50-Day Moving Average of the stock is 37.66%, while the 200-Day Moving Average is calculated to be 36.42%.
Shares Statistics:
According to the various share statistics, MEDP traded on average about 493.28K shares per day over the past 3-months and 1131150 shares per day over the past 10 days. A total of 28.02M shares are outstanding, with a floating share count of 22.64M. Insiders hold about 19.40% of the company’s shares, while institutions hold 92.77% stake in the company. Shares short for MEDP as of 1752537600 were 3058400 with a Short Ratio of 6.20, compared to 1749772800 on 3094745. Therefore, it implies a Short% of Shares Outstanding of 3058400 and a Short% of Float of 13.780000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
